- NAYA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
NAYA Biosciences (NAYA) CORRESPCorrespondence with SEC
Filed: 2 Aug 23, 12:00am
INVO BIOSCIENCE, INC.
5582 BROADCAST COURT
Sarasota, florida 32240
August 2, 2023
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | INVO Bioscience, Inc. | |
Registration Statement on Form S-1 | ||
File No. 333-273174 |
Ladies and Gentlemen:
INVO Bioscience, Inc. (the “Company”) hereby requests, pursuant to Rule 461 under the Securities Act of 1933, as amended, that the above-referenced registration statement be accelerated to 5:30 p.m., Eastern Time, on Thursday August 3, 2023, or as soon thereafter as practicable.
Very truly yours, | ||
INVO BIOSCIENCE, INC. | ||
By: | /s/ Steven Shum | |
Steven Shum | ||
Chief Executive Officer |